Design, synthesis and biological evaluation of novel 2,3-dihydroquinazolin- 4(1H)-one derivatives as potential fXa inhibitors
Keywords: Factor Xa; Anticoagulant; fXa inhibitor; Arteriovenous shunt; Bleeding risk; Thromboembolic diseases;